LivaNova PLC (LIVN)
LIVN trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$76.37
-1.17% on the day
Market cap
$4.2B
Mid cap
Revenue · 2025
$1.4B
+10.7% on 2024
Net income · 2025
-$242.5M
-17.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | LIVN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Country | United Kingdom |
| IPO year | Not reported by the screener |
| SEC CIK | 0001639691 |
| SEC industry code | Electromedical & Electrotherapeutic Apparatus |
| Incorporated in | X0 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.4B |
| Net income | -$242.5M |
| Operating income | $199.4M |
| Net margin | -17.5% |
| Operating margin | 14.4% |
| Revenue growth | +10.7% |
| Cash | $635.6M |
| Total assets | $2.6B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2021-08-05 |
| Latest annual report | 10-K | 2026-02-25 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 950 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.1% |
| 1 month | -4.6% |
| 3 months | -7.3% |
| Year to date | +23.3% |
| 1 year | +46.5% |
| From 52-week high | -11.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ITGR | Integer Holdings Corporation | $126.59 | +0.06% | $4.3B |
| TMDX | TransMedics Group Inc. | $79.14 | +1.23% | $2.7B |
| AXGN | Axogen Inc. | $36.17 | -2.53% | $2.1B |
| CNMD | CONMED Corporation | $45.55 | +0.42% | $1.4B |
| CBLL | CeriBell Inc. | $26.14 | +3.48% | $1.0B |
| INMD | InMode Ltd. | $14.30 | +0.04% | $822.3M |
| CV | CapsoVision Inc. | $6.78 | +0.30% | $360.7M |
| ELMD | Electromed Inc. | $27.68 | -1.53% | $229.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier